The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Targeted RNA Sequencing Market Research Report 2024
Synopsis
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
In the report, we only collect information about the companies who can provide targeted RNA sequencing service.
The global Targeted RNA Sequencing market was valued at US$ 1800.6 million in 2023 and is anticipated to reach US$ 7570 million by 2030, witnessing a CAGR of 22.5% during the forecast period 2024-2030.
Market competition is not intense. Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, etc. are the leaders of the industry, with about 52% market shares.
North America is the largest consumption place, with a consumption market share nearly 32%. Following North America, Europe is the second largest consumption place with the consumption market share of 28%.
This report aims to provide a comprehensive presentation of the global market for Targeted RNA Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted RNA Sequencing.
Report Scope
The Targeted RNA Sequencing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Targeted RNA Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Targeted RNA Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher
Illumina
Roche Holdings
BGI
Eurofins
LabCorp
Berry Genomics
Macrogen
GENEWIZ
Segment by Type
Exome Sequencing
Enrichment Sequencing
Amplicon Sequencing
Segment by Application
Research Institutes
Hospitals & Clinics
Biotechnology Company
Diagnostic Lab
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Targeted RNA Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
In the report, we only collect information about the companies who can provide targeted RNA sequencing service.
The global Targeted RNA Sequencing market was valued at US$ 1800.6 million in 2023 and is anticipated to reach US$ 7570 million by 2030, witnessing a CAGR of 22.5% during the forecast period 2024-2030.
Market competition is not intense. Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, etc. are the leaders of the industry, with about 52% market shares.
North America is the largest consumption place, with a consumption market share nearly 32%. Following North America, Europe is the second largest consumption place with the consumption market share of 28%.
This report aims to provide a comprehensive presentation of the global market for Targeted RNA Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted RNA Sequencing.
Report Scope
The Targeted RNA Sequencing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Targeted RNA Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Targeted RNA Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher
Illumina
Roche Holdings
BGI
Eurofins
LabCorp
Berry Genomics
Macrogen
GENEWIZ
Segment by Type
Exome Sequencing
Enrichment Sequencing
Amplicon Sequencing
Segment by Application
Research Institutes
Hospitals & Clinics
Biotechnology Company
Diagnostic Lab
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Targeted RNA Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted RNA Sequencing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Exome Sequencing
1.2.3 Enrichment Sequencing
1.2.4 Amplicon Sequencing
1.3 Market by Application
1.3.1 Global Targeted RNA Sequencing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Research Institutes
1.3.3 Hospitals & Clinics
1.3.4 Biotechnology Company
1.3.5 Diagnostic Lab
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted RNA Sequencing Market Perspective (2019-2030)
2.2 Targeted RNA Sequencing Growth Trends by Region
2.2.1 Global Targeted RNA Sequencing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Targeted RNA Sequencing Historic Market Size by Region (2019-2024)
2.2.3 Targeted RNA Sequencing Forecasted Market Size by Region (2025-2030)
2.3 Targeted RNA Sequencing Market Dynamics
2.3.1 Targeted RNA Sequencing Industry Trends
2.3.2 Targeted RNA Sequencing Market Drivers
2.3.3 Targeted RNA Sequencing Market Challenges
2.3.4 Targeted RNA Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted RNA Sequencing Players by Revenue
3.1.1 Global Top Targeted RNA Sequencing Players by Revenue (2019-2024)
3.1.2 Global Targeted RNA Sequencing Revenue Market Share by Players (2019-2024)
3.2 Global Targeted RNA Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Targeted RNA Sequencing Revenue
3.4 Global Targeted RNA Sequencing Market Concentration Ratio
3.4.1 Global Targeted RNA Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted RNA Sequencing Revenue in 2023
3.5 Targeted RNA Sequencing Key Players Head office and Area Served
3.6 Key Players Targeted RNA Sequencing Product Solution and Service
3.7 Date of Enter into Targeted RNA Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted RNA Sequencing Breakdown Data by Type
4.1 Global Targeted RNA Sequencing Historic Market Size by Type (2019-2024)
4.2 Global Targeted RNA Sequencing Forecasted Market Size by Type (2025-2030)
5 Targeted RNA Sequencing Breakdown Data by Application
5.1 Global Targeted RNA Sequencing Historic Market Size by Application (2019-2024)
5.2 Global Targeted RNA Sequencing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Targeted RNA Sequencing Market Size (2019-2030)
6.2 North America Targeted RNA Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Targeted RNA Sequencing Market Size by Country (2019-2024)
6.4 North America Targeted RNA Sequencing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted RNA Sequencing Market Size (2019-2030)
7.2 Europe Targeted RNA Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Targeted RNA Sequencing Market Size by Country (2019-2024)
7.4 Europe Targeted RNA Sequencing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Targeted RNA Sequencing Market Size (2019-2030)
8.2 Asia-Pacific Targeted RNA Sequencing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Targeted RNA Sequencing Market Size by Region (2019-2024)
8.4 Asia-Pacific Targeted RNA Sequencing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Targeted RNA Sequencing Market Size (2019-2030)
9.2 Latin America Targeted RNA Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Targeted RNA Sequencing Market Size by Country (2019-2024)
9.4 Latin America Targeted RNA Sequencing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted RNA Sequencing Market Size (2019-2030)
10.2 Middle East & Africa Targeted RNA Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Targeted RNA Sequencing Market Size by Country (2019-2024)
10.4 Middle East & Africa Targeted RNA Sequencing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Detail
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Targeted RNA Sequencing Introduction
11.1.4 Thermo Fisher Revenue in Targeted RNA Sequencing Business (2019-2024)
11.1.5 Thermo Fisher Recent Development
11.2 Illumina
11.2.1 Illumina Company Detail
11.2.2 Illumina Business Overview
11.2.3 Illumina Targeted RNA Sequencing Introduction
11.2.4 Illumina Revenue in Targeted RNA Sequencing Business (2019-2024)
11.2.5 Illumina Recent Development
11.3 Roche Holdings
11.3.1 Roche Holdings Company Detail
11.3.2 Roche Holdings Business Overview
11.3.3 Roche Holdings Targeted RNA Sequencing Introduction
11.3.4 Roche Holdings Revenue in Targeted RNA Sequencing Business (2019-2024)
11.3.5 Roche Holdings Recent Development
11.4 BGI
11.4.1 BGI Company Detail
11.4.2 BGI Business Overview
11.4.3 BGI Targeted RNA Sequencing Introduction
11.4.4 BGI Revenue in Targeted RNA Sequencing Business (2019-2024)
11.4.5 BGI Recent Development
11.5 Eurofins
11.5.1 Eurofins Company Detail
11.5.2 Eurofins Business Overview
11.5.3 Eurofins Targeted RNA Sequencing Introduction
11.5.4 Eurofins Revenue in Targeted RNA Sequencing Business (2019-2024)
11.5.5 Eurofins Recent Development
11.6 LabCorp
11.6.1 LabCorp Company Detail
11.6.2 LabCorp Business Overview
11.6.3 LabCorp Targeted RNA Sequencing Introduction
11.6.4 LabCorp Revenue in Targeted RNA Sequencing Business (2019-2024)
11.6.5 LabCorp Recent Development
11.7 Berry Genomics
11.7.1 Berry Genomics Company Detail
11.7.2 Berry Genomics Business Overview
11.7.3 Berry Genomics Targeted RNA Sequencing Introduction
11.7.4 Berry Genomics Revenue in Targeted RNA Sequencing Business (2019-2024)
11.7.5 Berry Genomics Recent Development
11.8 Macrogen
11.8.1 Macrogen Company Detail
11.8.2 Macrogen Business Overview
11.8.3 Macrogen Targeted RNA Sequencing Introduction
11.8.4 Macrogen Revenue in Targeted RNA Sequencing Business (2019-2024)
11.8.5 Macrogen Recent Development
11.9 GENEWIZ
11.9.1 GENEWIZ Company Detail
11.9.2 GENEWIZ Business Overview
11.9.3 GENEWIZ Targeted RNA Sequencing Introduction
11.9.4 GENEWIZ Revenue in Targeted RNA Sequencing Business (2019-2024)
11.9.5 GENEWIZ Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
